FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market: GlobalData
GlobalData highlights that the FDA’s review of Moderna’s mRNA-1010, with a 05 August 2026 PDUFA date, could introduce the first…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
NIT Rourkela startup receives CDSCO approval for StopBleed Hemostat
Institute spinout Miraqules MedSolutions secures regulatory clearance for technology aimed at emergency haemorrhage control
Alembic Pharmaceuticals receives USFDA approval for Efinaconazole Topical Solution, 10%
Product is therapeutically equivalent to Jublia; company holds 234 USFDA ANDA approvals
US and Japan present narrower path for Alzheimer’s drug approvals: GlobalData
Only two monoclonal antibodies approved in both markets with no small molecules cleared
Eris Lifesciences partners Natco Pharma to commercialise Semaglutide in India
CDSCO approval enables planned March 2026 launch targeting Type 2 diabetes management
Lupin receives European Commission approval for biosimilar ranibizumab RanluspecTM
Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU through Sandoz partnership
Updated Balance Requirements in the Pharmaceutical Industry
Laboratory balance requirements across global pharmacopeias have been significantly revised to improve clarity, harmonization, and…
Dr Reddy’s submits Abatacept Biosimilar BLA to USFDA for review
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid arthritis, psoriatic arthritis and pJIA
Morepen Laboratories secures ₹825 Cr CDMO mandate from global pharma company
Multi-year contract to commence supplies within 4–5 months, execution planned through Q1 of next financial year
Global Pain Therapeutics market shows scope for non-opioid Innovation: GlobalData
Report highlights voltage-gated sodium channel inhibitors, pipeline trends and regulatory incentives in pain treatment